These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 571124)
1. Resistance of alloxan-diabetic rats to the behavioral activation induced by d-amphetamine: partial restoration with a high fat/protein diet. Marshall JF Physiol Behav; 1978 Mar; 20(3):319-22. PubMed ID: 571124 [No Abstract] [Full Text] [Related]
2. Further analysis of the resistance of the diabetic rat to d-amphetamine. Marshall JF Pharmacol Biochem Behav; 1978 Mar; 8(3):281-6. PubMed ID: 565933 [TBL] [Abstract][Full Text] [Related]
3. Stereotyped behavior and diabetes mellitus in rats: reduced behavioral effects of amphetamine and apomorphine and reduced in vivo brain binding of [3H]spiroperidol. Rowland N; Joyce JN; Bellush LL Behav Neurosci; 1985 Oct; 99(5):831-41. PubMed ID: 3916385 [TBL] [Abstract][Full Text] [Related]
5. Behavioral depression and its neurochemical correlates at high doses of d-amphetamine in rats. Copeland RL; Aulakh CS; Bhattacharyya AK; Pradhan SN Neuropharmacology; 1980 Oct; 19(10):1027-30. PubMed ID: 7191484 [No Abstract] [Full Text] [Related]
7. Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy. Segal DS; Mandell AJ Pharmacol Biochem Behav; 1974; 2(2):249-55. PubMed ID: 4857295 [No Abstract] [Full Text] [Related]
8. The behavioral effects of D-amphetamine are correlated with its effects on cAMP in different brain regions. Kennedy LA; Zigmond MJ Brain Res; 1979 May; 168(2):408-13. PubMed ID: 221074 [No Abstract] [Full Text] [Related]
9. Enhanced responsiveness to intraventricular infusion of amphetamine following its repeated systemic administration. Rebec GV; Segal DS Psychopharmacology (Berl); 1979 Mar; 62(1):101-2. PubMed ID: 108743 [TBL] [Abstract][Full Text] [Related]
10. Enhanced locomotor activity following amphetamine in mouse-killing rats. Salama AI; Goldberg ME Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):162-9. PubMed ID: 4795753 [No Abstract] [Full Text] [Related]
11. Modulation of the behavioral effects of amphetamine in rats by clonidine. Mueller K; Nyhan WL Eur J Pharmacol; 1982 Sep; 83(3-4):339-42. PubMed ID: 6293845 [TBL] [Abstract][Full Text] [Related]
14. Interactions between ethanol and amphetamine in mice and rats. Spreux-Varoquaux O; Simon P Prog Neuropsychopharmacol; 1980; 4(1):13-8. PubMed ID: 7190719 [No Abstract] [Full Text] [Related]
15. Various effects of d-amphetamine in rats with selective lesions of brain noradrenaline - containing neurons or treated with penfluridol. Quattrone A; Bendotti C; Recchia M; Samanin R Commun Psychopharmacol; 1977; 1(6):525-31. PubMed ID: 564765 [No Abstract] [Full Text] [Related]
16. A comparative study of the behavioral effects of d-amphetamine and apomorphine in the rat. Antoniou K; Kafetzopoulos E Pharmacol Biochem Behav; 1991 May; 39(1):61-70. PubMed ID: 1924514 [TBL] [Abstract][Full Text] [Related]
17. [The significance of an increased protein and fat content in the food ration of rats for the development of stable alloxan diabetes]. Ul'ianov AM; Tarasov IuA Probl Endokrinol (Mosk); 1989; 35(6):78-81. PubMed ID: 2622891 [TBL] [Abstract][Full Text] [Related]
18. Reduced anorexic and locomotor-stimulant action of D-amphetamine in alloxan-diabetic rats. Marshall JF; Friedman MI; Heffner TG Brain Res; 1976 Jul; 111(2):428-32. PubMed ID: 949615 [No Abstract] [Full Text] [Related]
19. Effects of dietary protein and tyrosine on behavior of diabetic rats. Bellush LL; Rowland NE Am J Physiol; 1986 Aug; 251(2 Pt 2):R371-80. PubMed ID: 2943168 [TBL] [Abstract][Full Text] [Related]
20. Diminished reaction to a novel stimulus during amphetamine withdrawal in rats. Schreiber H; Bell R; Conely L; Kufner M; Palet J; Wright L Pharmacol Biochem Behav; 1976 Dec; 5(6):687-90. PubMed ID: 1035805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]